​
​

Akili Stock (NASDAQ:AKLI)

ForecastRevenueOwnershipFinancialsChartTranscripts
Akili by TradingView

Previous Close

$0.43

52W Range

$0.19 - $1.25

50D Avg

$0.40

200D Avg

$0.38

Market Cap

$34.10M

Avg Vol (3M)

$2.30M

Beta

1.73

Div Yield

-

AKLI Company Profile

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

68

IPO Date

Jun 30, 2021

Website

AKLI Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 22
Product$419.00K

Fiscal year ends in Dec 23 | Currency in USD

AKLI Financial Summary

Dec 23Dec 22Dec 21
Revenue$1.68M$323.00K$538.00K
Operating Income$-64.48M$-90.68M$-60.72M
Net Income$-59.49M$-7.96M$-61.83M
EBITDA$-60.14M$-90.68M$-60.42M
Basic EPS$-0.76$-0.10$-0.79
Diluted EPS$-0.76$-0.10$-0.79

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 23Nov 12, 23 | 8:03 AM
Q2 23Aug 13, 23 | 9:27 AM
Q1 23May 11, 23 | 12:00 AM

Peer Comparison

TickerCompany
FORAForian Inc.
ETAOETAO International Co., Ltd.
ACONAclarion, Inc.
NRCNational Research Corporation
STRMStreamline Health Solutions, Inc.
CPSITruBridge, Inc.
HQYHealthEquity, Inc.
AUGXAugmedix, Inc.
HSTMHealthStream, Inc.
HCATHealth Catalyst, Inc.
EUDAEUDA Health Holdings Limited